Immunovant raises $550M via 26.2M share offering at $21.00/share

Immunovant, Inc.

Gross proceeds ~$550M from 26.2M shares priced at $21.00/share.
Controlling stockholder Roivant Sciences Ltd. participated in the offering.
Offering closed December 12, 2025; Leerink Partners acted as underwriter.

item 8.01 item 9.01

Immunovant, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-317577

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.